Our mission is to become a leading provider of antibody-based technologies in the areas of healthcare and research.
We are committed to providing a high quality, reliable product that delivers accurate results in a timely manner.
Business Strategy
To become a leader in developing antibody-based technologies to aid in the detection of disease in humans and animals.
We will continuously explore innovative technologies to meet the demands of the public’s health both domestically and internationally.
History
Antibody Technologies, Inc. (ATI) was founded in 2003, in Atlanta, Georgia, with the primary intent to bring antibody-based technologies to the marketplace.
